Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The primary available study, Naessen et al
Improved Glycemic Control: Semaglutide helps regulate blood sugar levels, reducing the risk of complications associated with diabetes
Similar content being viewed by others Background Type 2 diabetes mellitus (T2DM), a common metabolic disorder characterized by insulin resistance and inadequate insulin secretion by pancreatic cells, has become a growing cause of morbidity and mortality worldwide
Do not use these products concomitantly with other semaglutide-containing products or with any other glucagon-like peptide-1 (GLP-1) receptor agonist
As with any medication, patients may experience: Mild to Moderate Nausea: Although it causes less nausea than other GLP-1 receptor agonists, some patients may still experience this symptom, especially when starting treatment
Rotating your injection sites, choosing healthy skin, and avoiding the exact same spot week after week can help lower the risk of irritation
